Human Molecular Genetics Advance Access published online on October 9, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm297
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LETM1, deleted in Wolf-Hirschhorn Syndrome is required for normal mitochondrial morphology and cellular viability
1 Dulbecco-Telethon Institute, Venetian Institute of Molecular Medicine, 35129 Padova ITALY 2 Section of Human Genetics, Dept. of Paediatrics, University of Padova, 35121 Padova ITALY 3 Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-University, 91054 Erlangen Germany
* to whom correspondence should be addressed. Istituto Veneto di Medicina Molecolare, Via Orus 2, 35129 Padova, Italy. Ph.: +390497923221; Fax: +390497923271; email: lscorrano{at}dti.telethon.it
Wolf-Hirschhorn-Syndrome (WHS) is a complex congenital syndrome caused by a monoallelic deletion of the short arm of chromosome 4. Seizures in WHS have been associated with deletion of LETM1 gene. LETM1 encodes for the human homologue of yeast Mdm38p, a mitochondria-shaping protein of unclear function. Here we show that human LETM1 is located in the inner membrane, exposed to the matrix and oligomerized in higher molecular weight complexes of unknown composition. Downregulation of LETM1 did not disrupt these complexes, but led to DRP1-independent fragmentation of the mitochondrial network. Fragmentation was not associated with changes in the levels of respiratory chain complexes, or with obvious or latent mitochondrial dysfunction, but was recovered by nigericin, which catalyzes the electroneutral exchange of K+ against H+. Downregulation of LETM1 caused "necrosis-like" death, without activation of caspases and not inhibited by overexpression of Bcl-2. Primary fibroblasts from a WHS patient displayed reduced LETM1 mRNA and protein, but mitochondrial morphology was surprisingly unaffected, raising the question of whether and how WHS patients counteract the consequences of monoallelic deletion of LETM1. LETM1 highlights the relationship between mitochondrial ion homeostasis, integrity of the mitochondrial network and cell viability.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Trevisson, A. Burlina, M. Doimo, V. Pertegato, A. Casarin, L. Cesaro, P. Navas, G. Basso, G. Sartori, and L. Salviati Functional Complementation in Yeast Allows Molecular Characterization of Missense Argininosuccinate Lyase Mutations J. Biol. Chem., October 16, 2009; 284(42): 28926 - 28934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Demaurex and D. Poburko A Revolving Door for Calcium Science, October 2, 2009; 326(5949): 57 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jiang, L. Zhao, and D. E. Clapham Genome-Wide RNAi Screen Identifies Letm1 as a Mitochondrial Ca2+/H+ Antiporter Science, October 2, 2009; 326(5949): 144 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Liesa, M. Palacin, and A. Zorzano Mitochondrial Dynamics in Mammalian Health and Disease Physiol Rev, July 1, 2009; 89(3): 799 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Piao, Y. Li, S. J. Kim, H. S. Byun, S. M. Huang, S.-K. Hwang, K.-J. Yang, K. A. Park, M. Won, J. Hong, et al. Association of LETM1 and MRPL36 Contributes to the Regulation of Mitochondrial ATP Production and Necrotic Cell Death Cancer Res., April 15, 2009; 69(8): 3397 - 3404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Correction for Szabo et al., Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes PNAS, November 11, 2008; 105(45): 17587 - 17587. [Full Text] [PDF]
|
|
|
|
|
|
I. Szabo, J. Bock, H. Grassme, M. Soddemann, B. Wilker, F. Lang, M. Zoratti, and E. Gulbins Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes PNAS, September 30, 2008; 105(39): 14861 - 14866. [Abstract] [Full Text] [PDF]
|
|